Global Continuous Renal Replacement Therapy (CRRT) Market Report 2022-2026: Increase in Incidence of Acute Kidney Injury to Drive Market Growth
Tuesday, September 20, 2022
DUBLIN, Aug. 22, 2022 /PRNewswire/ -- The "Continuous Renal Replacement Therapy (CRRT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026
Amid the COVID-19 crisis, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.7 Billion by 2026, registering a compounded annual growth rate (CAGR) of 5.8% over the analysis period.
Continuous renal replacement therapy (CRRT) is the most widely used therapy in critically ill patients as these hypotensive patients require slow removal of waste and water without causing hypotension. As renal replacement therapy for pediatric patients with Acute Kidney Injury (AKI) becomes more commonplace, CRRT gains traction as a suitable treatment modality for patients of any size and who are hemodynamically unstable. The growing prevalence of cardiovascular diseases is the underlying factor for acute kidney injury cases, which is expected to drive the demand for CRRT.
The United States represents the largest regional market for Continuous Renal Replacement Therapy (CRRT), and is projected to reach US$422.4 Million by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 8.3% over the analysis period.
The global Continuous Renal Replacement Therapy (CRRT) market is expected to increase rapidly in future, driven by rising incidence of acute kidney injury (AKI). AKI constitutes for about 60% mortality rate. CRRT is the most widely used treatment for AKI. The technique is the most preferred modality for treating and managing hemodynamically unstable patients with AKI.
Benefits of CRRT include hemodynamic tolerance due to solute removal and slower ultrafiltration. Rise in ageing population, increase in ICU-related admissions, and higher acceptance of CRRT procedures due to clinical advantages over the intermittent blood purification methods are the other key factors driving market growth.
As Renal replacement therapy (RRT) is required in patients with severe acute kidney injury (AKI), the rise in incidence of Acute Kidney Injury remains a major factor driving growth in the CRRT market. Renal disorders and kidney related ailments are also common among aged people, and spike in population of aged people inflates the potential patient population for CRRT treatments.
Europe and the United States dominate the Continuous Renal Replacement Therapy market, driven by the fast growing aging population and increasing acute kidney injury cases. Growth in Asia-Pacific region is attributable to increasing aging population, rising cases of acute kidney injury/diseases, increasing healthcare expenditure, technological advancements, and governments` push for investments in the healthcare sector.
The market for Continuous Venovenous Hemodiafiltration (CVVHDF) is forecast to grow at the fastest rate among all modalities over the analysis period. CVVHDF treatment modality leads to comprehensive removal and replacement of fluids and blood in the blood.
The modality combines the principles of convection and diffusion, hemodialysis and hemofiltration, by using an efficient hemodiafilter. Given the modality`s ability to eliminate solute as well as fluid, the CVVHDF segment is poised to grow at a strong pace in the coming years. CVVHDF is a modality that is generally preferred among hospitals equipped with well-established intensive care units.
What`s New for 2022?
-- Global competitiveness and key competitor percentage market shares
-- Market presence across multiple geographies -
Strong/Active/Niche/Trivial
-- Online interactive peer-to-peer collaborative bespoke updates
-- Access to the digital archives
-- Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
-- Influencer Market Insights
-- World Market Trajectories
-- Impact of Covid-19 and a Looming Global Recession
-- Continuous Renal Replacement Therapy Market Set for a Steady Growth
-- Dialysates & Replacement Fluids Dominate the Market, Disposables to
Register the Fastest Growth
-- Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to
Exhibit the Fastest Growth
-- Europe and US Hold the Largest Share, China to Witness Fastest Growth
-- Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors
Percentage Market Share in 2022 (E)
-- Future Endeavors in CRRT
2. FOCUS ON SELECT PLAYERS (Total 18 Featured)
-- Asahi Kasei Medical Co., Ltd.
-- B. Braun Melsungen AG
-- Baxter International, Inc.
-- Bellco Societa Unipersonale a r.l
-- Chongqing Shanwaishan Science and Technology Co., Ltd.
-- Fresenius Medical Care AG & Co. KgaA
-- Infomed SA
-- Medica SpA
-- Medical Components, Inc.
-- Medites Pharma Spol. S.R.O.
-- Medtronic PLC
-- Nikkiso Co., Ltd.
-- Ningbo Tianyi Medical Appliance Co., Ltd
-- NxStage Medical, Inc.
-- Toray Medical Co., Ltd.
3. MARKET TRENDS & DRIVERS
-- Increase in Incidence of Acute Kidney Injury to Drive Market Growth
-- Rise in Aging Population, Growing Number of ICU Patients Spurs the Need
for CRRT
-- Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
-- Increasing Incidence of Cardiovascular Disease Drive Market Growth
-- Prevalence of Heart Failure in Select Countries
-- Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
-- Technological Advancements to Bolster Market Growth
-- Development of CRRT System for Pediatric Patients
-- Miniaturization and Wearable Technology Forays into Acute Renal
Replacement Domain
-- Reimbursement Scenario
-- Development of New Hemofilters to Propel Market Expansion
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/fv5wif
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-continuous-renal-replacement-therapy-crrt-market-report-2022-2026-increase-in-incidence-of-acute-kidney-injury-to-drive-market-growth-301609776.html
SOURCE Research and Markets
|
|
|
|
|
 |
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
